Australian clinical tuberculosis network ACTnet logo
Australian Clinical Tuberculosis Network ACTnet logo

  • HOME

    • COVID-19
    • Newsletters
    • Podcasts
    • Education
    • What's On?

  • ABOUT ACTnet

    • Mission Statement
    • ACTnet Steering Committee
    • ACTnet Network Members

  • OUR RESEACH

    • Ongoing Research
    • Research Support

  • LINKS

  • CONTACT

  • More

    Use tab to navigate through the menu items.
    The effect of weekly rifapentine and isoniazid (3HP), compared to 4 months of daily rifampicin (4RIF) upon adherence with treatment for latent TB infection
    Evaluating the ‘cascade of care’ for latent tuberculosis infection (LTBI) among children: a platform for evidence-based approaches to TB elimination
    Contact us
    Email us
    Social media

    Get in touch via twitter  @actnet_tb 

    • Facebook Social Icon
    • Twitter Social Icon
    • Google+ Social Icon
    • YouTube Social Icon
    • Pinterest Social Icon
    • Instagram Social Icon